The new Johnson & Johnson vaccine is only this effective research show.
This new vaccine is less effective than others, but experts say you should not thank it yet.
WithCOVID Always scary more and more the United States, many people hope to stay safe by vaccinating. But withinsufficient quantities Pfizer and Moderna vaccines in many states, Americans are looking forward to learn more about the new new anticipatedJohnson & Johnson Covid Vaccine, which is probably the next one to be approved in the states.
Unlike modernization and Pfizer vaccines, Johnson & Johnson's inoculation is a single-dose vaccine, which means that its distribution could allow more people to be completely vaccinated earlier. However, the results of the clinical trial show that the vaccine is significantly less effective than the two vaccines currently administered in the United States to determine what it means in terms of protection, reading and vaccine updates. important, beware thatIf you have more than 65 years, you should not yet get this new vaccine, experts warn.
The results of the Johnson & Johnson phase trial returned.
January 29, Johnson & Johnson sharedAn analysis of his phase three test results. According to a statement by the Company, the vaccine is "66% effective globally to the prevention of CVIV-19 moderate to Grave, 28 days after vaccination". However, the vaccine has demonstrated higher efficiency to prevent serious illness. The inoculation of Johnson & Johnson is "85% overall efficiency in the prevention of serious illnesses and comprehensive protection against related hospitalization of Covid-19 and death in the 28th day."
It is less effective than Moderna and Pfizer vaccines, which are effective 94 and 95% to prevent Covid-19 symptoms, respectively, but that does not mean that it should be excluded in the fight against the virus. The previous yearvaccine against influenzaFor example, it is generally 40 to 60% effective, according to disease control and prevention centers (CDC), but it is still a recommended precaution against the flu virus. And for more COVID information up-to-date, delivered directly into your inbox,Sign up for our daily newsletter.
The experts say that Johnson & Johnson vaccine should be considered equivalent to that of Pfizer and Moderna.
INFECTIOUS EXPERT OF DISEASESMichael Osterholm, PhD, told CNN on January 29 he assesses Johnson & Johnson vaccine to be as effective as those in Pfizer and Moderna. "It's really, in my mind, three almostEquivalent vaccines, "Tell Osterholm.
Osterholm noted that the results of the Johnson & Johnson trial indicate only the immune response in the short term to the vaccine, explaining that the answer can become stronger with time. "The protection has improved the farthest you have come out of vaccination," Osterholm explained. "If we had followed that several months, it could have been an equal, if not superior vaccine, to what we see with Moderna and Pfizer." And for a side effect, you can see post-shot, checkThe rare side effect of Covid vaccine wants you to prepare.
Johnson & Johnson vaccine has shown lower abroad efficiency against other strains.
The Johnson & Johnson Declaration noted that, while the vaccine proved to be effective 72% in the United States, only 57% in force in South Africa, where nearly 95% of cases Cospher comes from the South African strain of the virus. With cases of theSouth African covidant strain Recently appeared in the United States, it could potentially affect the effectiveness of the stateside vaccine, also over time. For more information on the South African covidant strain, check whyThe chief medicine of Moderna has just given this upsetting update.
Johnson & Johnson vaccine has two advantages over Pfizer and Moderna vaccines.
Johnson & Johnson vaccine comes in a single dose, unlike Pfizer and Moderna vaccines. The single dose allows more people to become totally vaccinated earlier than possible with two dose vaccines, which require three to four weeks to flow between the first and second plans, depending on the vaccine you get.
In addition, Johnson & Johnson vaccine does not need to be kept at the ultra-low temperatures needed to ensure the safety of Pfizer and Modern vaccines. The Johnson & Johnson vaccine can be stored for at least three months in the refrigerator preserved between 36 degrees Fahrenheit and 46 degrees Fahrenheit. This mitigates the number of vaccines that can go to waste if it is not used quite quickly and allows itLargest vaccine access Parties of the country where special vaccine storage equipment can be short-circuited.
"We can keep it in our refrigerators longer. We do not have to worry about extreme temperature problems," osterholm said. "For many clinics, this will be the ideal vaccine to have. A dose. Stable vaccine." And before you go to your vaccine appointment, checkThe 2 things you need to do before you get vaccinated, the study says.
The Johnson & Johnson vaccine will probably be ready for approval in February.
While Johnson & Johnson's vaccine still needs to be approved for use by the Food and Drug Administration (FDA), the company expressed its optimism that would soon be on the market. According to the Johnson & Johnson Declaration, the Company "intends to file an authorization to use US emergencies (EUA) in early February and expects products to be available to ship immediately after the authorization" . And if you want to play safe after your shot, find out whyDr. Fauci says that after being vaccinated is a huge mistake.
